The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

R Borrow, P Alarcón, J Carlos, DA Caugant… - Expert review of …, 2017 - Taylor & Francis
ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed
the global importance of meningococcal disease (MD) and its continually changing …

Global epidemiology of meningococcal disease

LH Harrison, CL Trotter, ME Ramsay - Vaccine, 2009 - Elsevier
As reviewed in this paper, meningococcal disease epidemiology varies substantially by
geographic area and time. The disease can occur as sporadic cases, outbreaks, and large …

[HTML][HTML] Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis

D Bogaert, B Keijser, S Huse, J Rossen, R Veenhoven… - PloS one, 2011 - journals.plos.org
The nasopharynx is the ecological niche for many commensal bacteria and for potential
respiratory or invasive pathogens like Streptococcus pneumoniae, Haemophilus influenzae …

Meningococcal disease: clinical presentation and sequelae

D Pace, AJ Pollard - Vaccine, 2012 - Elsevier
The clinical spectrum of invasive meningococcal disease is diverse with meningitis and/or
septicaemia being the commonest modes of presentation. The severity of manifestations of …

[HTML][HTML] Meningococcal carriage and disease—population biology and evolution

DA Caugant, MCJ Maiden - Vaccine, 2009 - Elsevier
Meningococcal disease occurs worldwide with incidence rates varying from 1 to 1000 cases
per 100,000. The causative organism, Neisseria meningitidis, is an obligate commensal of …

[HTML][HTML] Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and …

RA Adegbola, R DeAntonio, PC Hill, A Roca, E Usuf… - PloS one, 2014 - journals.plos.org
Background Infection with Streptococcus pneumoniae is a major cause of childhood
morbidity and mortality worldwide, especially in low income countries where pneumococcal …

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs

CL Trotter, MCJ Maiden - Expert review of vaccines, 2009 - Taylor & Francis
Effective vaccines provide direct protection to immunized individuals, but may also provide
benefits to unvaccinated individuals by reducing transmission and thereby lowering the risk …

[HTML][HTML] Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans

SO Sow, BJ Okoko, A Diallo, S Viviani… - … England Journal of …, 2011 - Mass Medical Soc
Background Group A meningococci are the source of major epidemics of meningitis in
Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed …

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution

FM LaForce, N Ravenscroft, M Djingarey, S Viviani - Vaccine, 2009 - Elsevier
Epidemic meningitis in Africa remains an important and unresolved public health problem.
Bacteriologic and epidemiologic data collected over the past 30 years have consistently …

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine

O Xie, AJ Pollard, JE Mueller, G Norheim - Vaccine, 2013 - Elsevier
Neisseria meningitidis is responsible for the seasonal burden and recurrent epidemics of
meningitis in an area of sub-Saharan Africa known as the meningitis belt. Historically, the …